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Abstract
Background
Multiple viruses are often detected in children with respiratory infection but the significance
of co-infection in pathogenesis, severity and outcome is unclear.
Objectives
To correlate the presence of viral co-infection with clinical phenotype in children admitted
with acute respiratory infections (ARI).
Methods
We collected detailed clinical information on severity for children admitted with ARI as part
of a Spanish prospective multicenter study (GENDRES network) between 2011–2013. A
nested polymerase chain reaction (PCR) approach was used to detect respiratory viruses
in respiratory secretions. Findings were compared to an independent cohort collected in the
UK.
Results
204 children were recruited in the main cohort and 97 in the replication cohort. The number
of detected viruses did not correlate with any markers of severity. However, bacterial super-
infection was associated with increased severity (OR: 4.356; P-value = 0.005), PICU admis-
sion (OR: 3.342; P-value = 0.006), higher clinical score (1.988; P-value = 0.002) respiratory
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support requirement (OR: 7.484; P-value < 0.001) and longer hospital length of stay (OR:
1.468; P-value < 0.001). In addition, pneumococcal vaccination was found to be a protective
factor in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU admis-
sion (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 0.021) respiratory
support requirement (OR: 0.324; P-value = 0.016) and oxygen necessity (OR: 0.328; P-
value = 0.001). All these findings were replicated in the UK cohort.
Conclusion
The presence of more than one virus in hospitalized children with ARI is very frequent but it
does not seem to have a major clinical impact in terms of severity. However bacterial super-
infection increases the severity of the disease course. On the contrary, pneumococcal vac-
cination plays a protective role.
Introduction
Molecular techniques including polymerase chain reaction (PCR) have increased the sensitivity
of detection for common and emerging respiratory viruses, and often reveal the presence of
more than one pathogen in respiratory patients.[1],[2] The importance of viral co-infections in
the pathogenesis, severity or course of respiratory infections is not well established. The high
sensitivity of molecular techniques raises questions about the clinical relevance of positive test
results. The presence of a virus does not necessarily indicate causation of clinical symptoms or
disease [3]. On the contrary, bacterial co-infection is usually associated with a more severe dis-
eases course and worse prognosis, despite the precise interaction between bacteria and viruses
is not always clear.
Our study aims to analyze the relationship between viral or bacterial co-infection detected
by molecular methods, and the clinical phenotype of children admitted to hospital with lower
tract acute respiratory infections (LT-ARI).
Materials and Methods
Study design and recruitment criteria
Two independent observational prospective patient groups were enrolled in Spain (main
group) and in the United Kingdom (replication group). Spanish children were recruited
between January 2011 and January 2013 through a national hospital based research network:
GENDRES (Genetic, vitamin D and Respiratory infections research network– www.gendres.
org), which includes 13 Spanish tertiary hospitals. UK children were recruited between October
2009 and May 2010 at St Mary’s hospital (UK). In both cohorts, eligible study participants
were children under 14 years of age with a lower respiratory tract illness of sufficient severity to
warrant admission to hospital, and a virus identified on nasopharyngeal swab or aspirate sam-
ple. All types of LT-ARI were included, from bronchiolitis to pneumonia, with or without
wheezing, fever, rhinorrhea and respiratory distress.
A nasopharyngeal sample (aspirate or swab) was obtained during admission for viral patho-
gen detection. Besides the diagnostic procedures performed at origin in the referring hospital,
viral detection was performed in all recruited subjects using a panel of 19 viruses, by nested
PCR: respiratory syncytial virus; influenza virus (A, B); parainfluenza virus types (1–4); adeno-
virus (A-F); rhinovirus; metapneumovirus; coronavirus (NL63, 229E, OC43) and bocavirus
(Methods previous described in Cebey-López et al. [4]). No difference was found on the molec-
ular diagnosis yield in our series when using aspirate or swab as sample source.
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Clinical data collection
Detailed clinical data on each patient were collected using a secured web-based platform. This
included risk factors for LT-ARI (prematurity, immunization status, obesity, diabetes, asthma
and previous admissions to hospital), current medications, and family history of asthma or
other respiratory diseases. The severity of each respiratory case was ranked as follows: 1) physi-
cian criteria (mild, moderate or severe); 2) Wood-Downes scale (0 to 10 points; mild< 3, mod-
erate 4–7, severe> 8); and 3) a newly developed scale -named GENVIP score- (0 to 20 points)
that assesses food tolerance, degree of medical intervention needed, respiratory distress, respi-
ratory frequency, apnea, malaise and fever (see S1 Table for further details on this scale). Sup-
plemental oxygen and / or mechanical ventilation requirement during admission were also
recorded. Bacterial superinfection diagnosis was established according to the referring physi-
cian criteria, based on clinical data, inflammatory markers, and radiological findings, and/or
appropriate cultures in sterile sites (e.g blood or cerebrospinal fluid). For the study purposes,
cases classified as bacterial co-infections included both cases with and without microbiological
confirmation as in our series, cultures were not carried out systematically, but only when a bac-
terial superinfection was suspected by the referring physician.
Data analysis
In this analysis, we compared clinical data to the results of pathogen identification in respira-
tory samples. We performed all the analysis using the R Software, Version 3.0.2 (www.r-
project.org). General data were presented as means with 95% confidence intervals (CI). Differ-
ent statistical models were used to assess the bivariate association between the variables
depending on the dependent variable. The relationship between demographic and clinical vari-
ables with mono-infection and co-infection was analysed using simple logistic regression. A
binary logistic model was used for the binary variables (co-infection status, oxygen require-
ments, respiratory support needed and PICU admission), linear model for continuous variables
(Wood-Downes Score and GENVIP Score), negative binomial regression model for counted
data (hospital stay length) and logistic multinomial model for the multinomial variable (respi-
ratory distress status). Multiple regression models were considered using the significant risk
factors obtained in the bivariate analysis and sex and age variables. In order to reduce the likeli-
hood of false significant results due to too many statistical comparisons, the Bonferroni multi-
ple test correction were considered. A χ2 test was performed to evaluate the correlation
between bacterial superinfection and pneumococcal vaccine. Level of statistical significance
was set at 0.05.
Results
The GENDRES cohort included nasopharyngeal samples from 204 patients with a median age
of 16.7 (95% CI: 12.7–20.6) months and a male-to-female sex ratio of 1.7. One patient was
excluded due to incomplete clinical data. In the UK a cohort of 97 patients’ data was analyzed,
with a median of age of 36.6 (95% CI: 27.6–45.6) months and a male-to-female ratio of 0.94 (S1
Fig). Comparison between both cohorts is shown in Table 1.
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Viral mono-infection versus viral multi-infection
The PCR results were preciously described in Cebey-López et al. [4]. Clinical data, family or
past medical history, need of PICU admission or hospital length of stay, and oxygen or respira-
tory support need, were equivalent in the GENDRES and the UK cohort (Table 2).
In the GENDRES cohort the presence of rhinovirus as co-pathogen was associated with a
significantly increased Wood-Downes score by 1.289 points (95% CI: 0.387, 2.192); P-
value = 0.006. RSV infection was associated with increased oxygen requirements [OR (95%
CI): 3.154 (1.302, 7.966); P-value = 0.012] (Table 3). These isolated findings were not replicated
in the UK cohort (Table 3).
Bacterial superinfection
Children presenting a bacterial superinfection had more severe respiratory distress [OR (95%
CI): 4.356 (1.564, 12.128); P-value = 0.005] and a higher severity score [2.124 (95% CI: 0.864,
3.385); P-value = 0.001]. They were more likely to be admitted to PICU in the GENDRES
cohort [OR (95% CI): 2.851 (1.300, 6.252); P-value = 0.009] and the UK cohort [5.357 (2.081,
15.085); P-value = 0.001]. Children with bacterial co-infection required significantly more
respiratory support in both cohorts: discovery cohort [OR (95% CI): 6.368 (2.724, 14.886); P-
value< 0.001] and replication cohort [OR (95% CI): 3.432 (1.402, 8.404); P-value = 0.007],
and they had a longer hospital stay in both cohorts: 1.48 days (P-value = 0.025) longer stay in
GENDRES cohort and 1.87 days (P-value = 0.005) in UK cohort, respectively (Fig 1; S3–S8
Tables). In addition, 34.0% of the patients with bacterial infection in the GENDRES cohort
received the pneumococcal vaccine and 24.7% did not receive it (P-value = 0.213).
Table 1. Description of the characteristics of the two cohorts analyzed: the GENDRES cohort and the UK cohort. P-value results from the compari-
son between both cohorts. A P-value < 0.05 was considered significant.
Variable GENDRES cohort n (%) UK cohort n (%) P-value
Sex (female proportion) 1 75 (36.9) 50 (51.5) 0.018
Age (months) 1 <0.001β
0–12 136 (66.7) 39 (40.2)
13–24 25 (12.3) 17 (17.5)
25–48 26 (12.8) 17 (17.5)
<48 16 (7.9) 24 (24.7)
Pneumoccocal vaccine1 110 (53.9) 57 (64.0) 0.124
Bacterial superinfection1 56 (29.5) 53 (54.6) <0.001β
Mono-infection1 95 (46.6) 56 (57.7) 0.084
RSV 53 (28.3) 21 (24.7)
Rhinovirus 17 (9.1) 12 (14.1)
Co-infection1 92 (49.2) 29 (34.1) 0.012
RSV + rhinovirus 23 (12.3) 3 (3.5)
RSV+ bocavirus 10 (5.3) 5 (5.9)
PICU admission1 38 (29.0) 43 (44.3) 0.024
Respiratory support1 30 (14.8) 36 (38.3) <0.001β
Oxygen needed1 56 (29.5) 55 (57.9) <0.001β
Hospital stay length2* 6 (4, 9) 4 (2, 9) <0.001β
1Fisher Exact Test.
2Wilcoxon test.
*Median and interquartile range in days.
βSigniﬁcant under Bonferroni correction.
doi:10.1371/journal.pone.0152481.t001
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Table 2. Relationship between demographic and clinical variables with mono-infection and co-infection is shown for both GENDRES and UK
cohort. The correlation was analysed using simple logistic regression. Data are presented as OR (95% confidence interval) and P-value. The characteristics
of the two cohorts analyzed were compared and when P-value results were significant when different: the GENDRES cohort and the UK cohort. P-value
results from the comparison between both cohorts. A P-value < 0.005 was considered significant.
Variable GENDRES cohort (n = 203) UK-cohort (n = 97)
GENDRES%
(95% CI)
OR (95%
CI)
P-
value
Multiple OR
(95% CI)
P
-value
UK-cohort
% (95% CI)
OR (95%
CI)
P
-value
Multiple OR
(95% CI)
P
-value
Demographic characteristics
Sex. Female 36.9 1.287 0.405 1.069 0.838 51.5 1.228 0.657 1.14 0.802
(30.3, 43.6) (0.711,
2.340)
(0.564, 2.014) (41.1, 62.0) (0.498,
3.086)
(0.41, 3.18)
Age β
12–24 months 12.3 3.723 0.010 3.173 0.028 17.5 8.937 0.002 8.73 0.002
(7.8 16.8) (1.428,
10.955)
(1.177, 9.569) (9.4, 25.6) (2.377,
40.192)
(2.3, 39.66)
24–48 months 12.8 4.189 0.005 3.463 0.018 17.5 1.773 0.378 1.79 0.372
(8.2, 17.4) (1.635,
12.201)
(1.290, 10.447) (9.4, 25.6) (0.484,
6.373)
(0.49, 6.44)
> 48 months 7.9 0.621 0.447 0.544 0.339 24.7 0.867 0.836 0.84 0.802
(4.2, 11.6) (0.161,
2.015)
(0.139, 1.800) (15.6, 33.9) (0.203,
3.261)
(0.19, 3.24)
Family history
Asthma 39.9 0.753 0.343 n.a.
(33.2, 46.6) (0.417,
1.352)
Respiratory
conditions
15.8 0.824 0.623 n.a.
(10.8, 20.9) (0.375,
1.785)
Patient medical history
Premature birth 8.5 0.450 0.199 n.a.
(4.5, 12.5) (0.118,
1.443)
Pneumococcal
vaccine
53.9 2.055 0.016 1.550 0.176 64.0 1.990 0.189
(47.1, 60.8) (1.151,
3.709)
(0.821,2.932) (54.1, 74.0) (0.734,
5.849)
Pulmonary
conditions
3.5 0.517 0.453 n.a.
(0.9, 6.0) (0.070,
2.718)
Asthma 11.8 0.943 0.899 n.a
(7.4, 16.3) (0.374,
2.354)
Clinical data
Bacterial
superinfection
29.5 1.396 0.308 54.6 1.319 0.549
(23.0, 36.0) (0.736,
2.667)
(44.2, 65.1) (0.536,
3.315)
βSigniﬁcant under Bonferroni correction.
doi:10.1371/journal.pone.0152481.t002
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Pneumococcal vaccine
In the GENDRES cohort the pneumococcal vaccine was given to 53.9% (46.9, 61.1) of the
patients of whom 43.8% (33.3, 54.2) were mono-infected and 62.7% (52.2, 73.1) were viral co-
infected patients [OR (95% CI): 1.550 (0.821, 2.932); P-value = 0.176]. Vaccinated patients had
lower risk of being admitted to PICU in GENDRES cohort [OR (95% CI): 0.301 (0.116, 0.735);
P-value = 0.011] and in the UK cohort [OR (95% CI): 0.208 (0.046, 0.776); P-value = 0.027]
and had less risk of respiratory support requirement in the main cohort [OR (95% CI): 0.324
(0.124, 0.790); P-value = 0.016] and in the replication one [OR (95% CI): 0.267 (0.070, 0.901);
P-value = 0.040]. In the Spanish cohort, patients who received the pneumococcal vaccine
received less oxygen support [OR (95% CI): 0.328 (0.162, 0.639); P-value = 0.001], and had a
lower clinical severity score [-1.499 (95% CI: -2.768, -0.231) points; P-value = 0.021] and a
lower respiratory distress score [OR (95% CI): 2.917 (1.078, 7.889); P-value = 0.035]. These
findings were not replicated in the UK cohort (Fig 1; S1–S7 Tables).
Table 3. Comparison of virus and disease severity of the main cohort considering the virus as single pathogen or as co-infection in the sample.
Different statistical models were considered to study the bivariate association between the variables depending on the dependent variable. A binary logistic
model was used for the binary variables oxygen needed and respiratory support needed, and a negative binomial regression model for counted data (hospital
stay length). Data are presented as OR (confidence interval 95%) and the level of statistical significance was set at 0.05.
Risk Factor Hospital stay
length
Oxygen needed Respiratory
support
Wood Downes score GENVIP score PICU admission
(n = 163) (n = 186) (n = 186) (n = 177) (n = 125) (n = 119)
OR
(95% CI)
P
-value
OR
(95% CI)
P
-value
OR (95%
CI)
P–
value
Coefﬁcient
(95% CI)
P
-value
Coefﬁcient
(95% CI)
P
-value
OR
(95% CI)
P
-value
Mono-
infected
RSV 1.092 0.450 3.154 0.012 3.556 0.122 0.571 0.188 1.384 0.107 1.121 0.846
(0.868,
1.374)
(1.302,
7.966)
(0.832,
24.487)
(-0.284,1.425) (-0.307,
3.075)
(0.362,
3.728)
Rhinovirus 0.785 0.154 0.327 0.042 1.167 0.854 -0.823 0.144 -1.134 0.447 1.410 0.623
(0.562,
1.094)
(0.109,
0.962)
(0.165,
5.257)
(-1.932, 0.285) (-4.095,
1.826)
(0.330,
5.410)
Bocavirus 0.999 0.997 0.435 0.327 -0.187 0.859 -2.610 0.111
(0.646,
1.548)
(0.076,
2.482)
(-2.270, 1.897) (-5.840,
0.619)
Adenovirus 1.211 0.456 0.859 0.413 1.581 0.624
(0.733,
2.019)
(-1.217, 2.935) (-4.841,
8.002)
Co-infected
RSV 1.150 0.281 0.938 0.892 1.550 0.456 -0.222 0.646 0.243 0.815 1.426 0.597
(0.892,
1.481)
(0.361,
2.364)
(0.509,
5.328)
(-1.217, 2.935) (-1.829,
2.316)
(0.402,
5.887)
Rhinovirus 1.443 0.003 1.642 0.288 2.921 0.085 1.289 0.006 0.920 0.379 2.169 0.146
(1.135,
1.836)
(0.658,
4.158)
(0.923,
11.199)
(0.387, 2.192) (-1.157,
2.997)
(0.104,
1.398)
Bocavirus 0.697 0.003 1.243 0.642 0.889 0.832 -0.654 0.168 -0.551 0.589 1.174 0.794
(0.551,
0.883)
(0.499,
3.168)
(0.290,
2.632)
(-1.590, 0.282) (-2.583,
1.481)
(0.352,
3.910)
Adenovirus 0.938 0.613 1.000 1.000 0.682 0.515 0.290 0.553 -0.848 0.422 1.426 0.597
(0.730,
1.204)
(0.396,
2.604)
(0.198,
22.080)
(-0.677, 1.257) (-2.947,
1.252)
(0.383,
5.305)
doi:10.1371/journal.pone.0152481.t003
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Discussion
Our study revealed that even though multiple viral detection is frequent in hospitalized chil-
dren with LT-ARI, this association is not related to either disease severity or to any other clini-
cal features studied. PICU admission, disease severity according to different scales, need for
respiratory support, and length of hospital stay followed a similar pattern in viral mono- versus
co-infected children. Contrariwise, bacterial superinfection increased the severity of the disease
course, while pneumococcal vaccination played a protective role.
The detection of multiple coincident viruses in clinical settings is becoming more common
since the introduction of molecular based multiplex tests, but the clinical significance of these
findings remains unclear and seems to have no impact in disease severity [5]. Both an increase
in disease severity in relation to dual infections [6–9] and the absence of this association [10–
19] have been reported. Richard et al. [8] found that co-infected children were almost three
times more likely to be admitted to the PICU than those with single viral infections. Compared
to our study Richard et al. developed a retrospective and monocentric study in which they only
considered dual infections, infants and bronchiolitis.
There is contradictory evidence linking disease severity with specific respiratory viruses. A
shorter hospital stay has been reported in children with rhinovirus bronchiolitis than with RSV
[20]. Rhinovirus and RSV co-infection is reported to increase the risk of severe disease [8] or
Fig 1. Influence of bacterial superinfection, pneumococcal vaccine and the presence of viral co-
infection on disease severity of children with ARI, according to oxygen and respiratory support
requirement, clinical scales, hospital stay length and PICU admission.Data are shown as OR (95%CI)
for both main cohort and replication cohort. A binary logistic model was used for the binary variables (co-
infection status, oxygen requirements, respiratory support needed and PICU admission), linear model for
continuous variables (Wood-Downes Score and the GENVIP score) and negative binomial regression model
for counted data (number of days since admission).
doi:10.1371/journal.pone.0152481.g001
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the bronchiolitis relapse [21, 22]. Other studies did not find significant differences in severity
between co-infection and single infection [12, 18, 23, 24]. In our study we did not find
increased severity of illness in children with RSV-rhinovirus dual infection. In our series, only
RSV as mono-infection increased oxygen requirements, and rhinovirus as a co-infecting patho-
gen increased the Wood-Downes score in the Spanish cohort, but these isolated findings aris-
ing from the multivariate analysis could not be replicated in the UK cohort.
Several studies have reported increased severity with bocavirus (hBoV) co-infections [13,
25–27]; this was not the case in our series (also in agreement with Pen et al. [15]). hBoV was
commonly detected in our patients, with no impact in the severity of the illness. As hBoV was
detected in alongside other respiratory viruses with an established pathogenic potential, it is
possible that hBoV detection reflects asymptomatic persistence or prolonged viral shedding
[28].
Bacterial superinfection was the only factor consistently linked to greater severity. Studies of
the pandemic influenza indicate that respiratory viruses predispose to bacterial complication
and interaction between viruses and bacteria in respiratory infections has been extensively
reported in the literature [29], but the underlying mechanisms between viral and bacterial syn-
ergism are complex and remain unclear [30]. Common respiratory viral infections, such as
influenza or respiratory syncytial virus have been linked to seasonal increases in Streptococcus
pneumoniae disease [31]. The relationship between bacterial and viral infection is clouded by
the low sensitivity of bacterial detection in sterile-site samples by traditional culture methods,
and the reliance on non-specific clinical data for the for diagnosis of bacterial co-infection,
including inflammatory markers, radiological findings and / or appropriate cultures, resulting
in 30% of the cases in the GENDRES cohort and 55% in the UK cohort. Bacterial superinfec-
tion increased most measures of severity in both cohorts (PICU admission, respiratory support
requirement, GENVIP score, hospital stay length and respiratory distress).
Interestingly, pneumococcal vaccination was revealed as an independent protective factor of
disease severity in our patients. Pneumococcal vaccine reduced the severity of viral LT-ARIs
through a reduction in oxygen requirement, invasive and non-invasive ventilation, admission
to PICU, respiratory distress, and GENVIP score. A reduced incidence of viral alveolar pneu-
monia has been previously reported after pneumococcal vaccination [31, 32], although there
was no demonstrable reduction in the number of confirmed pneumococcal infections. This is
likely to reflect the limited sensitivity of culture-proven pneumococcal disease in pneumonia.
The protective effect of pneumococcal vaccines found in our study might reinforce the impor-
tance of the paradigm of viral-penumococci interaction at nasopharynx level in the pathogene-
sis and clinical course of the disease [33] Current pneumococcal conjugate vaccines
significantly decrease nasopharyngeal carriage of pneumococci [34] and thus reduces the possi-
bility of this viral-pneumococci direct interaction.
One of the limitations of the present study is that our samples were not tested for viral load
by quantitative PCR and the viral load of certain viruses–like RSV- has been associated with
the co-infection status and the severity [3]. Also, the study did not consider milder or asymp-
tomatic children. In addition, bacterial superinfection rate in our series might be overestimated
as diagnosis was accepted as true even without microbiological confirmation, just based on
referring physicians’ criteria.
Several studies had shown that viruses can be found in children with no respiratory infec-
tions [6, 35], and further research is needed to understand the natural history of respiratory
viral carriage and infection. However, our findings were consistent in both independent
cohorts very different between them, so this makes the outcomes more robust.
In summary, the severity and course of an acute respiratory episode requiring hospitaliza-
tion in children did not correlate with the presence of one or more viruses. In contrast, bacterial
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co-infection was associated with more severe disease, whereas pneumococcal vaccination
decreased severity. Future studies are needed to investigate whether particular viruses, or com-
binations of viruses, influence the risk of bacterial co-infection.
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